Latest News in the pharma Industry
Research & Development
Cambrex completes new $3.2M analytical R&D laboratory at its High Point, NC Facility
24 Apr 2018
The aboratory’s primary function is to broaden analytical support for customer projects being developed and manufactured at the High Point site.
Read more
Manufacturing collaboration to advance PMD-026 toward IND
18 Apr 2018
MD-026 is the first RSK inhibitor to demonstrate potential disease-modifying properties in triple-negative breast cancer.
Read more
Omega-3s from fish oil supplements no better than placebo for dry eye
15 Apr 2018
NIH-funded study finds omega-3 fails to yield beneficial results in the clinic.
Read more.jpg)
Hope on the horizon for hair loss sufferers
13 Mar 2018
First patient treated in Follicum’s Phase IIa study of FOL-005 for stimulation of hair growth.
Read more
Biogen to acquire first-in-class Phase IIb ready asset for cognitive impairment
12 Mar 2018
PF-04958242 is an AMPA receptor potentiator designed to facilitate neurotransmission.
Read more.png)
New Cosentyx data look promising for patients with scalp psoriasis
21 Feb 2018
Majority of patients with scalp psoriasis on Cosentyx (secukinumab) achieved clear skin at Weeks 12 and 24 and improved quality of life.
Read more.png)
Lonza to establish cell- and gene-therapy Centers of Excellence to accelerate growth
20 Feb 2018
The Centers of Excellence will allow custoners to access customer-centric solutions.
Read more
Expanded GXP compliance increases Concept's breadth of services
9 Feb 2018
Successful MHRA inspection at Dundee site confirms GLP accreditation for in vitro safety studies and bioanalysis.
Read more.jpg)
'Effective' hair loss treatment candidate advances to Phase IIa
7 Feb 2018
German Medicines Agency sees potential in FOL-005 - a modified version of the endogenous protein, osteopontin - the green light for further studies.
Read more
Metrion Biosciences awarded £200k funding to further develop in-house drug discovery pipeline
6 Feb 2018
Funding will support further development of recently acquired small molecule assets for treatment of autoimmune disease.
Read more
Lab automation systems for faster scientific breakthroughs
5 Feb 2018
PAA showcases its complete range of automation solutions, suitable for any type of laboratory or application, at SLAS2018.
Read more
Sanofi, DNDi seek EMA review for sleeping sickness treatment
1 Feb 2018
Fexinidazole would be first all-oral treatment under investigation for both first and second stages of sleeping sickness, a fatal disease, endemic in Africa.
Read more